Literature DB >> 8851599

Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates.

M Perilli1, A Felici, A Oratore, G Cornaglia, G Bonfiglio, G M Rossolini, G Amicosante.   

Abstract

The beta-lactamases produced by Acinetobacter lwoffii ULA-501, Acinetobacter baumannii ULA-187, and A. baumannii AC-14 strains were purified and characterized, and their kinetic interactions with several beta-lactam molecules, including substrates and inhibitors, were studied in detail. The three enzymes appeared to be cephalosporinases with different acylation efficiencies (kcat/Km ratio values), and their hydrolytic activities were inhibited by benzylpenicillin, piperacillin, and cefotaxime, which did not behave as substrates. Carbenicillin was a substrate for the beta-lactamase from A. lwoffii ULA-501, whereas it acted as a transient inactivator of the enzymes produced by the two A. baumannii strains. Clavulanic acid was unable to inactivate the three beta-lactamases, whereas sulbactam behaved as an inactivator only at a high concentration (1 mM) which is difficult to achieve during antibiotic therapy. Analysis of the interaction with 6-beta-iodopenicillanic acid also allowed us to better discriminate the three beta-lactamases analyzed in the present study, which can be included in the group 1 functional class (5).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851599      PMCID: PMC163186     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

Authors:  W H Traub; M Spohr
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  The diversity of the catalytic properties of class A beta-lactamases.

Authors:  A Matagne; A M Misselyn-Bauduin; B Joris; T Erpicum; B Granier; J M Frère
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

3.  Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance.

Authors:  K Sato; T Nakae
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

4.  Novel carbenicillin-hydrolyzing beta-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus.

Authors:  G Paul; M L Joly-Guillou; E Bergogne-Berezin; P Névot; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1989-05       Impact factor: 2.742

5.  Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.

Authors:  B G Kuah; G Kumarasinghe; J Doran; H R Chang
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

6.  A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.

Authors:  M Galleni; G Amicosante; J M Frère
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

7.  Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus.

Authors:  M L Joly-Guillo; E Vallée; E Bergogne-Bérézin; A Philippon
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

8.  Purification and characterization of an extracellular beta-lactamase produced by Acinetobacter calcoaceticus.

Authors:  B Blechschmidt; P Borneleit; H P Kleber
Journal:  J Gen Microbiol       Date:  1992-06

9.  Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.

Authors:  M Gehrlein; H Leying; W Cullmann; S Wendt; W Opferkuch
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

10.  Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.

Authors:  M Obara; T Nakae
Journal:  J Antimicrob Chemother       Date:  1991-12       Impact factor: 5.790

View more
  14 in total

1.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii.

Authors:  G Bou; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii.

Authors:  Migma Dorji Tamang; Shukho Kim; Sung-Min Kim; Hyun-Hee Kong; Jungmin Kim
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

4.  Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactams.

Authors:  Hedi Mammeri; Laurent Poirel; Nicole Mangeney; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

5.  OmpA is the principal nonspecific slow porin of Acinetobacter baumannii.

Authors:  Etsuko Sugawara; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

6.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes.

Authors:  Kristine M Hujer; Nashaat S Hamza; Andrea M Hujer; Federico Perez; Marion S Helfand; Christopher R Bethel; Jodi M Thomson; Vernon E Anderson; Miriam Barlow; Louis B Rice; Fred C Tenover; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

9.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

Review 10.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.